Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern-era clinical studies Read More > December 1, 2020
Post-Marketing Safety Concerns with Esketamine: A Disproportionality Analysis of Spontaneous Reports Submitted to the FDA Adverse Event Reporting System Read More > December 1, 2020
Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine Read More > November 30, 2020
Combining Ketamine, Brain Stimulation (rTMS) and Mindfulness Therapy (TIMBER) for Opioid Addiction Read More > November 30, 2020
Is ketamine an appropriate alternative to ECT for patients with treatment resistant depression? A systematic review Read More > November 30, 2020
Corticosterone as a Potential Confounding Factor in Delineating Mechanisms Underlying Ketamine’s Rapid Antidepressant Actions Read More > November 30, 2020
MDMA-assisted psychotherapy for treatment of anxiety and other psychological distress related to life-threatening illnesses: a randomized pilot study Read More > November 24, 2020
Increased signal diversity/complexity of spontaneous EEG, but not evoked EEG responses, in ketamine-induced psychedelic state in humans Read More > November 23, 2020
The Effects of Ketamine on Cognition in Treatment-Resistant Depression: A Systematic Review and Priority Avenues for Future Research Read More > November 23, 2020
